Rattusin, an intestinal α-defensin-related peptide in rats with a unique cysteine spacing pattern and salt-insensitive antibacterial activities

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1823-1831

  Patil, Amar A ^a,d   Ouellette, Andre J ^b   Lu, Wuyuan ^c   Zhang, Guolong ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d Animal Health Diagnostic Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; ANTIINFECTIVE AGENT; CYSTEINE; MAGNESIUM ION; RATTUSIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIUM CULTURE; CYTOTOXICITY TEST; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN SITU HYBRIDIZATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PANETH CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMALL INTESTINE;

ALPHA-DEFENSINS; AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BETA-DEFENSINS; CACO-2 CELLS; CYSTEINE; HUMANS; IN SITU HYBRIDIZATION; INTESTINE, SMALL; KLEBSIELLA PNEUMONIAE; LISTERIA MONOCYTOGENES; MOLECULAR SEQUENCE DATA; PEPTIDES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, AMINO ACID; STAPHYLOCOCCUS AUREUS;

EID: 84875165782     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02237-12     Document Type: Article

References (53)

1. Finch RG. 2004. Antibiotic resistance: a view from the prescriber. Nat. Rev. Microbiol. 2:989 -994.
2. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389 -395.
3. Hancock RE, Sahl HG. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
4. Brogden KA. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238 -250.
5. Selsted ME, Ouellette AJ. 2005. Mammalian defensins in the antimicrobial immune response. Nat. Immunol. 6:551-557.
6. Lehrer RI. 2004. Primate defensins. Nat. Rev. Microbiol. 2:727-738.
7. Ganz T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3:710 -720.
8. Zanetti M. 2004. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 75:39-48.
9. Andersson ML, Karlsson-Sjoberg JM, Putsep KL. 2012. CRS-peptides: unique defense peptides of mouse Paneth cells. Mucosal Immunol. 5:367-376.
10. Yang D, Biragyn A, Hoover DM, Lubkowski J, Oppenheim JJ. 2004. Multiple roles of antimicrobial defensins, cathelicidins, and eosinophilderived neurotoxin in host defense. Annu. Rev. Immunol. 22:181-215.
11. Kim C, Slavinskaya Z, Merrill AR, Kaufmann SH. 2006. Human alphadefensins neutralize toxins of the mono-ADP-ribosyltransferase family. Biochem. J. 399:225-229.
12. Kim C, Gajendran N, Mittrucker HW, Weiwad M, Song YH, Hurwitz R, Wilmanns M, Fischer G, Kaufmann SH. 2005. Human alphadefensins neutralize anthrax lethal toxin and protect against its fatal consequences. Proc. Natl. Acad. Sci. U. S. A. 102:4830-4835.
13. Wilson CL, Ouellette AJ, Satchell DP, Ayabe T, Lopez-Boado YS, Stratman JL, Hultgren SJ, Matrisian LM, Parks WC. 1999. Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286:113-117.
14. Tongaonkar P, Golji AE, Tran P, Ouellette AJ, Selsted ME. 2012. High fidelity processing and activation of the human alpha-defensin HNP1 precursor by neutrophil elastase and proteinase 3. PLoS One 7:e32469. doi: 10.1371/journal.pone.0032469.
15. Glenthøj A, Cowland JB, Heegaard NH, Larsen MT, Borregaard N. 2011. Serglycin participates in retention of alpha-defensin in granules during myelopoiesis. Blood 118:4440-4448.
16. Ghosh D, Porter E, Shen B, Lee SK, Wilk D, Drazba J, Yadav SP, Crabb JW, Ganz T, Bevins CL. 2002. Paneth cell trypsin is the processing enzyme for human defensin-5. Nat. Immunol. 3:583-590.
17. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. 2003. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 422:522-526.
18. Wehkamp J, Salzman NH, Porter E, Nuding S, Weichenthal M, Petras RE, Shen B, Schaeffeler E, Schwab M, Linzmeier R, Feathers RW, Chu H, Lima H, Jr, Fellermann K, Ganz T, Stange EF, Bevins CL. 2005. Reduced Paneth cell alpha-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. U. S. A. 102:18129 -18134.
19. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, Stoel M, Zhou Y, Sodergren E, Weinstock GM, Bevins CL, Williams CB, Bos NA. 2010. Enteric defensins are essential regulators of intestinal microbial ecology. Nat. Immunol. 11:76-83.
20. Tremaroli V, Backhed F. 2012. Functional interactions between the gut microbiota and host metabolism. Nature 489:242-249.
21. Wu Z, Hoover DM, Yang D, Boulegue C, Santamaria F, Oppenheim JJ, Lubkowski J, Lu W. 2003. Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. U. S. A. 100:8880-8885.
22. Maemoto A, Qu X, Rosengren KJ, Tanabe H, Henschen-Edman A, Craik DJ, Ouellette AJ. 2004. Functional analysis of the alpha-defensin disulfide array in mouse cryptdin-4. J. Biol. Chem. 279:44188-44196.
23. Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME. 1999. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 286: 498-502.
24. Patil A, Hughes AL, Zhang G. 2004. Rapid evolution and diversification of mammalian alpha-defensins as revealed by comparative analysis of rodent and primate genes. Physiol. Genomics 20:1-11.
25. De Block M, Debrouwer D. 1993. RNA-RNA in situ hybridization using digoxigenin-labeled probes: the use of high-molecular-weight polyvinyl alcohol in the alkaline phosphatase indoxyl-nitroblue tetrazolium reaction. Anal. Biochem. 215:86-89.
26. Ayabe T, Satchell DP, Pesendorfer P, Tanabe H, Wilson CL, Hagen SJ, Ouellette AJ. 2002. Activation of Paneth cell alpha-defensins in mouse small intestine. J. Biol. Chem. 277:5219 -5228.
27. Shirafuji Y, Tanabe H, Satchell DP, Henschen-Edman A, Wilson CL, Ouellette AJ. 2003. Structural determinants of procryptdin recognition and cleavage by matrix metalloproteinase-7. J. Biol. Chem. 278:7910-7919.
28. Hornef MW, Putsep K, Karlsson J, Refai E, Andersson M. 2004. Increased diversity of intestinal antimicrobial peptides by covalent dimer formation. Nat. Immunol. 5:836-843.
29. Gill SC, von Hippel PH. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:319 -326.
30. Satchell DP, Sheynis T, Shirafuji Y, Kolusheva S, Ouellette AJ, Jelinek R. 2003. Interactions of mouse Paneth cell alpha-defensins and alphadefensin precursors with membranes. Prosegment inhibition of peptide association with biomimetic membranes. J. Biol. Chem. 278:13838 - 13846.
31. Wu Z, Ericksen B, Tucker K, Lubkowski J, Lu W. 2004. Synthesis and characterization of human alpha-defensins 4-6. J. Pept. Res. 64:118 -125.
32. Xiao Y, Cai Y, Bommineni YR, Fernando SC, Prakash O, Gilliland SE, Zhang G. 2006. Identification and functional characterization of three chicken cathelicidins with potent antimicrobial activity. J. Biol. Chem. 281:2858 -2867.
33. Xiao Y, Dai H, Bommineni YR, Soulages JL, Gong YX, Prakash O, Zhang G. 2006. Structure-activity relationships of fowlicidin-1, a cathelicidin antimicrobial peptide in chicken. FEBS J. 273:2581-2593.
34. Xiao Y, Herrera AI, Bommineni YR, Soulages JL, Prakash O, Zhang G. 2009. The central kink region of fowlicidin-2, an alpha-helical host defense peptide, is critically involved in bacterial killing and endotoxin neutralization. J. Innate Immun. 1:268 -280.
35. Darmoul D, Ouellette AJ. 1996. Positional specificity of defensin gene expression reveals Paneth cell heterogeneity in mouse small intestine. Am. J. Physiol. 271:G68-G74.
36. Ouellette AJ, Darmoul D, Tran D, Huttner KM, Yuan J, Selsted ME. 1999. Peptide localization and gene structure of cryptdin 4, a differentially expressed mouse Paneth cell alpha-defensin. Infect. Immun. 67:6643-6651.
37. Wehkamp J, Chu H, Shen B, Feathers RW, Kays RJ, Lee SK, Bevins CL. 2006. Paneth cell antimicrobial peptides: topographical distribution and quantification in human gastrointestinal tissues. FEBS Lett. 580:5344-5350.
38. Rinderknecht H, Renner IG, Abramson SB, Carmack C. 1984. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 86:681-692.
39. Ouellette AJ. 2004. Defensin-mediated innate immunity in the small intestine. Best Pract. Res. Clin. Gastroenterol. 18:405-419.
40. Bowdish DM, Davidson DJ, Hancock RE. 2005. A re-evaluation of the role of host defence peptides in mammalian immunity. Curr. Protein Pept. Sci. 6:35-51.
41. Friedrich C, Scott MG, Karunaratne N, Yan H, Hancock RE. 1999. Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob. Agents Chemother. 43:1542-1548.
42. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock RE. 2005. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77: 451-459.
43. Morrison GM, Rolfe M, Kilanowski FM, Cross SH, Dorin Jr. 2002. Identification and characterization of a novel murine beta-defensinrelated gene. Mamm. Genome 13:445-451.
44. White SH, Wimley WC, Selsted ME. 1995. Structure, function, and membrane integration of defensins. Curr. Opin. Struct. Biol. 5:521-527.
45. Chu H, Pazgier M, Jung G, Nuccio SP, Castillo PA, de Jong MF, Winter MG, Winter SE, Wehkamp J, Shen B, Salzman NH, Underwood MA, Tsolis RM, Young GM, Lu W, Lehrer RI, Baumler AJ, Bevins CL. 2012. Human alpha-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. Science 337:477-481.
46. Schroeder BO, Wu Z, Nuding S, Groscurth S, Marcinowski M, Beisner J, Buchner J, Schaller M, Stange EF, Wehkamp J. 2011. Reduction of disulphide bonds unmasks potent antimicrobial activity of human betadefensin 1. Nature 469:419-423.
47. Andersson HS, Figueredo SM, Haugaard-Kedstrom LM, Bengtsson E, Daly NL, Qu X, Craik DJ, Ouellette AJ, Rosengren KJ. 2012. The alpha-defensin salt-bridge induces backbone stability to facilitate folding and confer proteolytic resistance. Amino Acids 43:1471-1483.
48. Nei M, Xu P, Glazko G. 2001. Estimation of divergence times from multiprotein sequences for a few mammalian species and several distantly related organisms. Proc. Natl. Acad. Sci. U. S. A. 98:2497-2502.
49. Shanahan MT, Tanabe H, Ouellette AJ. 2011. Strain-specific polymorphisms in Paneth cell alpha-defensins of C57BL/6 mice and evidence of vestigial myeloid alpha-defensin pseudogenes. Infect. Immun. 79:459-473.
50. Nuding S, Zabel LT, Enders C, Porter E, Fellermann K, Wehkamp J, Mueller HA, Stange EF. 2009. Antibacterial activity of human defensins on anaerobic intestinal bacterial species: a major role of HBD-3. Microbes Infect. 11:384 -393.
51. Ericksen B, Wu Z, Lu W, Lehrer RI. 2005. Antibacterial activity and specificity of the six human alpha-defensins. Antimicrob. Agents Chemother. 49:269 -275.
52. Bevins CL. 2006. Paneth cell defensins: key effector molecules of innate immunity. Biochem. Soc. Trans. 34:263-266.
53. Agerberth B, Gudmundsson GH. 2006. Host antimicrobial defence peptides in human disease. Curr. Top. Microbiol. Immunol. 306:67-90.